PUBLIC CITIZEN for PUBLIC CITIZEN
What was lobbied
12 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Executive Compensation reforms in reconciliation, Bright Lines Project Legislation, Country by country tax reporting, Revenue proposals for COVID relief bills, progressive tax pay fors for reconciliation package, Progressive tax policies, Financial transaction tax, Financial transaction tax as revenue source for COVID recovery funding, international tax provisions and reconciliation, Progressive tax revenue options
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN ELAINE HARLEY | — |
| BARTLETT NAYLOR | — |
| EMILY PETERSON CASSIN | — |
| ROBERT STEWART | — |
Consumer Issues/Safety/Products CSP
Regulatory reform, Forthcoming House and Senate privacy legislation, AI rulemaking, Upcoming guidance on AI and hiring, Congressional review Act, Stop Corporate Capture Act, Safe sleep for babies Act, Off-highway vehicles
| Lobbyist | Covered position, as disclosed |
|---|---|
| REMINGTON GREGG | — |
| MATT KENT | — |
| AMIT NARANG | — |
| EMILY PETERSON CASSIN | — |
Government Issues GOV
For the People Act-S1, Protecting our democracy act (PODA), Revolving door policy for the FDA, War Powers and National Emergencies Act (NSPA), National Security Powers Act (S 2391), Ban Conflicted trading act (HR 1579, S 564), Coronavirus Oversight and Recovery Ethics act (CORE Act),
| Lobbyist | Covered position, as disclosed |
|---|---|
| CRAIG HOLMAN | — |
Pharmacy PHA
HR3778/S 1976 (NOVID Act); Covid-19 Vaccine manufacturing and access and related funding, HR 3 (Lower Drug Costs Now Act, Senate Finance Drug price reform package, Aducanumab, Drug pricing, Insulin affordability for all Act, Medicare Negotiation and Competitive Licensing Act, We PAID Act, S. 1435-Affordable Prescriptions for Patients Act, Vaccine manufacturing and NDAA
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN KNIEVEL | — |
Health Issues HCR
Build Back Better American Families Plan/Medicare expansion, Medicare for all, Medicare Improvement and expansion
| Lobbyist | Covered position, as disclosed |
|---|---|
| EAGAN KEMP | — |
Trade (domestic/foreign) TRD
Trade-domestic and international
| Lobbyist | Covered position, as disclosed |
|---|---|
| LORI WALLACH | — |
Banking BAN
Congressional review act vote on OCC-"fair lender rule", ESG disclosure, Executive compensation reforms
| Lobbyist | Covered position, as disclosed |
|---|---|
| BARTLETT NAYLOR | — |
Labor Issues/Antitrust/Workplace LBR
HR 3816-American Choice and Innovative Online Act, HR 3825-Ending Platform Monopolies Act, HR 3826-Platform Competition and Opportunity Act of 2021, HR 3843-Merging Filing Fee Modernization Act, HR 3849-ACCESS act of 2021, HR 3460-State Antitrust Enforcement Venue Act of 2021, Antitrust reform, Heat Stress
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULEY FULCHER | — |
| JASON ALEXANDER HARMAN | — |
Budget/Appropriations BUD
OSHA appropriations
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULEY FULCHER | — |
Computer Industry CPI
Issues related to privacy, issues related to competition
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE CHUNG | — |
Communications/Broadcasting/Radio/TV COM
Forthcoming 230 bill
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY PETERSON CASSIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.